Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapiesCharli E Harlow, Timothy M. Frayling, Andrew R. Wood et al.|The American Journal of Human Genetics|2022Cited by 13
Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular riskCharli E Harlow, Timothy M. Frayling, Vickas V. Patel et al.|Human Molecular Genetics|2022Cited by 0